» Articles » PMID: 23798774

Characterization and Antimicrobial Activity of N-Methyl-2-pyrrolidone-loaded Ethylene Oxide-Propylene Oxide Block Copolymer Thermosensitive Gel

Overview
Specialty Pharmacy
Date 2013 Jun 27
PMID 23798774
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study is to investigate the effects of N-methyl-2-pyrrolidone on the thermosensitive properties of aqueous ethylene oxide-propylene oxide block copolymer (Lutrol(®) F127) system. Due to the aqueous solubility enhancement and biocompatibility, N-methyl-2-pyrrolidone is an interesting solubilizer for the poorly water soluble drugs to be incorporated in the Lutrol(®) F127 system. Effect of N-methyl-2-pyrrolidone on physicochemical properties of Lutrol(®) F127 system was investigated using appearance, pH, gelation, gel melting temperature and rheology. The antimicrobial activity of the thermosensitive N-methyl-2-pyrrolidone gel was also tested. Lower N-methyl-2-pyrrolidone amount (≤30%w/w) could shift the sol-gel transition to a lower temperature but the gel-sol transition was shifted to a higher temperature. Higher N-methyl-2-pyrrolidone (≥40%w/w) could shift both sol-gel and gel-sol transitions of the system to a lower temperature. The amount of N-methyl-2-pyrrolidone >60% w/w could reverse the phase of the Lutrol(®) F127 system to non-newtonian flow at 4° and Newtonian flow at high temperature. Aqueous Lutrol(®) F127 system containing N-methyl-2-pyrrolidone exhibited antimicrobial activities against Staphylococcus aureus, Escherichia coli and Candida albicans with the N-methyl-2-pyrrolidone in a dose-dependent manner.

Citing Articles

New Nanobioceramics Based on Hydroxyapatite for Biomedical Applications: Stability and Properties.

Ciobanu C, Predoi D, Iconaru S, Negrila C, Leduc D, Ghegoiu L Nanomaterials (Basel). 2025; 15(3).

PMID: 39940201 PMC: 11820604. DOI: 10.3390/nano15030224.


Cellulose Acetate Butyrate-Based In Situ Gel Comprising Doxycycline Hyclate and Metronidazole.

Khaing E, Lertsuphotvanit N, Thammasut W, Rojviriya C, Chansatidkosol S, Phattarateera S Polymers (Basel). 2025; 16(24.

PMID: 39771329 PMC: 11728690. DOI: 10.3390/polym16243477.


Moxifloxacin HCl -loaded Cellulose Acetate Butylate In Situ Forming Gel for Periodontitis Treatment.

Thammasut W, Rojviriya C, Chaiya P, Phaechamud T, Limsitthichaikoon S AAPS PharmSciTech. 2024; 25(7):242.

PMID: 39402367 DOI: 10.1208/s12249-024-02960-1.


Process Development for Fabricating 3D-Printed Polycaprolactone-Infiltrated Hydroxyapatite Bone Graft Granules: Effects of Infiltrated Solution Concentration and Agitating Liquid.

Thammarakcharoen F, Srion A, Suvannapruk W, Chokevivat W, Limtrakarn W, Suwanprateeb J Biomedicines. 2024; 12(9).

PMID: 39335674 PMC: 11429199. DOI: 10.3390/biomedicines12092161.


Fluconazole-Loaded Ibuprofen In Situ Gel-Based Oral Spray for Oropharyngeal Candidiasis Treatment.

Khaing E, Senarat S, Jitrangsri K, Phaechamud T AAPS PharmSciTech. 2024; 25(5):89.

PMID: 38641711 DOI: 10.1208/s12249-024-02804-y.


References
1.
Shin S, Cho C . Physicochemical characterizations of piroxicam-poloxamer solid dispersion. Pharm Dev Technol. 1998; 2(4):403-7. DOI: 10.3109/10837459709022639. View

2.
Schmolka I . Artificial skin. I. Preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Mater Res. 1972; 6(6):571-82. DOI: 10.1002/jbm.820060609. View

3.
Polson A, Garrett S, Stoller N, Bandt C, Hanes P, Killoy W . Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. II. Clinical results. J Periodontol. 1997; 68(2):119-26. DOI: 10.1902/jop.1997.68.2.119. View

4.
Yong C, Choi J, Quan Q, Rhee J, Kim C, Lim S . Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium. Int J Pharm. 2001; 226(1-2):195-205. DOI: 10.1016/s0378-5173(01)00809-2. View

5.
Scherlund M, Malmsten M, Holmqvist P, Brodin A . Thermosetting microemulsions and mixed micellar solutions as drug delivery systems for periodontal anesthesia. Int J Pharm. 1999; 194(1):103-16. DOI: 10.1016/s0378-5173(99)00366-x. View